Find insights on China’s healthcare sector, Thomson Medical Group, Cochlear, and more in the latest Market Talks covering the ...

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...

Heid, a China hawk who helped set technology policy for the congressional committee, is being tapped to be assistant ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

President Donald Trump plans to nominate Landon Heid, who served on the staff of the House of Representatives' Select ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Initially, it was suggested that BIO, a membership trade organisation for biotech, had been lobbying on behalf of WuXi AppTec and against the BIOSECURE Act. However, in a reversal, the ...

For a small island of just over 5 million people on Europe's western edge, Ireland is playing an outsize role in the travel ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

The Hong Kong stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it ...

MSD Ireland's robust R&D pipeline of therapeutic projects ensures it is ready to meet the diverse needs of patients globally ...